Topic Paragraphs
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Jun 27
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
Drugs
Jun 26
Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu
Food & Beverages
Jun 25
Mellace Family Brands California, Inc. Issues An Allergy Alert On Undeclared Milk Allergen In Wegmans Semi-Sweet Chocolate Nonpareils
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
The 2024 New Drug Therapy Approvals report features drug approvals that CDER considers likely to have a significant impact on public health.
Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum
FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
Recently Published Guidances
Jul 03
Small Volume Parenteral Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum Content and Labeling Recommendations
Drugs
Jul 02
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment
Biologics, Drugs
Jun 27
Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
Biologics, Medical Devices